PL2968139T3 - Platforma miejscowego podania mikroemulsji - Google Patents

Platforma miejscowego podania mikroemulsji

Info

Publication number
PL2968139T3
PL2968139T3 PL14720786T PL14720786T PL2968139T3 PL 2968139 T3 PL2968139 T3 PL 2968139T3 PL 14720786 T PL14720786 T PL 14720786T PL 14720786 T PL14720786 T PL 14720786T PL 2968139 T3 PL2968139 T3 PL 2968139T3
Authority
PL
Poland
Prior art keywords
application platform
microemulsion
topical
topical microemulsion
platform
Prior art date
Application number
PL14720786T
Other languages
English (en)
Polish (pl)
Inventor
Ronald A. Wassel
Fadee George Mondalek
Rafal A. Farjo
Alexander B. QUIAMBAO
Didier J NUNO
Original Assignee
EyeCRO, LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by EyeCRO, LLC filed Critical EyeCRO, LLC
Publication of PL2968139T3 publication Critical patent/PL2968139T3/pl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/216Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/12Ketones
    • A61K31/122Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/192Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/658Medicinal preparations containing organic active ingredients o-phenolic cannabinoids, e.g. cannabidiol, cannabigerolic acid, cannabichromene or tetrahydrocannabinol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0048Eye, e.g. artificial tears
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/107Emulsions ; Emulsion preconcentrates; Micelles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/107Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Dispersion Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Emergency Medicine (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Inorganic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PL14720786T 2013-03-14 2014-03-13 Platforma miejscowego podania mikroemulsji PL2968139T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361784005P 2013-03-14 2013-03-14
EP14720786.4A EP2968139B1 (en) 2013-03-14 2014-03-13 Microemulsion topical delivery platform
PCT/US2014/025773 WO2014160079A1 (en) 2013-03-14 2014-03-13 Microemulsion topical delivery platform

Publications (1)

Publication Number Publication Date
PL2968139T3 true PL2968139T3 (pl) 2018-10-31

Family

ID=50628949

Family Applications (1)

Application Number Title Priority Date Filing Date
PL14720786T PL2968139T3 (pl) 2013-03-14 2014-03-13 Platforma miejscowego podania mikroemulsji

Country Status (12)

Country Link
US (2) US8968775B2 (enExample)
EP (1) EP2968139B1 (enExample)
JP (1) JP6348567B2 (enExample)
CN (1) CN105451718B (enExample)
AU (1) AU2014244154B2 (enExample)
CA (1) CA2905023C (enExample)
DK (1) DK2968139T3 (enExample)
ES (1) ES2673009T3 (enExample)
PL (1) PL2968139T3 (enExample)
PT (1) PT2968139T (enExample)
TR (1) TR201808197T4 (enExample)
WO (1) WO2014160079A1 (enExample)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2007272839B2 (en) 2006-07-13 2012-05-24 Achillion Pharmaceuticals, Inc. 4-amino-4-oxobutanoyl peptides as inhibitors of viral replication
ES2584534B1 (es) * 2015-03-27 2017-03-13 Retinset, S.L. Formulación tópica oftálmica de bosentan
EP3405183A4 (en) 2016-01-18 2019-12-11 Arisan Therapeutics Inc. ADAMATE DERIVATIVES FOR TREATING A FILOVIRUS INFECTION
ES2706535T3 (es) * 2016-07-07 2019-03-29 Salvat Lab Sa Composiciones oftálmicas que comprenden aceite de ricino y triglicéridos de cadena media
US11548893B2 (en) 2017-07-15 2023-01-10 Arisan Therapeutics Inc. Enantiomerically pure adamantane carboxamides for the treatment of filovirus infection
EP3672587A4 (en) * 2017-08-27 2021-05-19 Rhodes Technologies PHARMACEUTICAL COMPOSITIONS INTENDED FOR THE TREATMENT OF OPHTHALMIC DISORDERS
US11583497B2 (en) 2017-11-14 2023-02-21 The Schepens Eye Research Institute, Inc. Nano-emulsion of CBFß-RUNX1 inhibitor for ocular drug delivery
CN114245737A (zh) 2019-06-11 2022-03-25 司斐股份有限公司 微乳剂组合物
EP3998063A4 (en) * 2019-07-08 2023-03-15 MORESCO Corporation Compositions for preparing microemulsion, microemulsion, method for producing composition and microemulsion, and use of microemulsion
US20240415796A1 (en) * 2020-11-19 2024-12-19 Nihon University Eyedrops for ameliorating or preventing retinal circulation disorder and retinal neurovascular coupling disorder
ES3032065T3 (en) * 2021-10-01 2025-07-15 Univ South Africa A nano emulsified phyto-drug for transdermal treatment of diabetes
CN119789854A (zh) * 2023-08-04 2025-04-08 Ads医疗有限责任公司 用于递送眼科活性物的组合物和方法
WO2025090133A1 (en) 2023-10-23 2025-05-01 Inmed Pharmaceuticals Inc. Compositions and methods for use of cannabinol compounds in neuroprotection

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI398261B (zh) * 2003-12-17 2013-06-11 Alcon Inc 血清類澱粉a基因於診斷及治療青光眼及鑑定抗青光眼劑上之用途
US7569612B1 (en) * 2006-08-21 2009-08-04 Mutual Pharmaceutical Company, Inc. Methods of use of fenofibric acid
US20090082470A1 (en) * 2007-09-24 2009-03-26 Rafal Farjo Stat3 inhibiting compositions and methods
US8652443B2 (en) * 2008-02-14 2014-02-18 Precision Dermatology, Inc. Foamable microemulsion compositions for topical administration
CA2827082A1 (en) * 2011-02-11 2012-08-16 Psivida Us, Inc. Methods of treating macular edema using antiedema therapeutics
WO2013049621A1 (en) * 2011-09-29 2013-04-04 The Board Of Regents Of The University Of Oklahoma Ophthalmic compositions comprising ppar-alpha agonists and methods of production and use thereof

Also Published As

Publication number Publication date
US8968775B2 (en) 2015-03-03
CN105451718A (zh) 2016-03-30
PT2968139T (pt) 2018-06-18
DK2968139T3 (en) 2018-06-25
AU2014244154B2 (en) 2018-08-09
JP6348567B2 (ja) 2018-06-27
ES2673009T3 (es) 2018-06-19
CA2905023C (en) 2019-10-15
TR201808197T4 (tr) 2018-07-23
EP2968139B1 (en) 2018-05-23
EP2968139A1 (en) 2016-01-20
CN105451718B (zh) 2018-09-28
US20140275263A1 (en) 2014-09-18
WO2014160079A1 (en) 2014-10-02
US9149453B2 (en) 2015-10-06
JP2016512562A (ja) 2016-04-28
CA2905023A1 (en) 2014-10-02
AU2014244154A1 (en) 2015-09-24
US20150164846A1 (en) 2015-06-18

Similar Documents

Publication Publication Date Title
FIC20210025I1 (fi) Lumasiraani
DK3342773T3 (da) Syk-hæmmere
EP2989885A4 (en) HARVESTER
PL2968139T3 (pl) Platforma miejscowego podania mikroemulsji
LT3038654T (lt) Naujas panaudojimas
PT3055308T (pt) Resumo
DK3044389T3 (da) Vinduespost-tværstykke-konstruktion
EP2970310A4 (en) 5-BROMO-indirubins
BR112015032639A2 (pt) Guindaste
DK2973500T3 (da) Bevægelsesplatformkonfiguration
PT3022200T (pt) Novos agentes antimaláricos
ES1078715Y (es) Mosquitera
BR302013006223S1 (pt) Configuração aplicada em gabarito
FI20130007L (fi) Työteline
BR302013002964S1 (pt) Configuração aplicada em sandalia
BR302013002004S1 (pt) Configuração aplicada em bombona
FI10779U1 (fi) Energiapuukoura
UA28560S (uk) Розгортка опакування
UA28553S (uk) Розгортка опакування
UA28557S (uk) Розгортка опакування
UA28558S (uk) Розгортка опакування
UA28559S (uk) Розгортка опакування
UA28550S (uk) Розгортка опакування
UA28561S (uk) Розгортка опакування
UA28562S (uk) Розгортка опакування